ClinicalTrials.gg
CompletedNCT03831347TeenThriveUpdated Mar 23, 2022Results posted

Treatments for Improving Mood in Depressed Teens-2

An interventional study of Hatha Yoga in Depression, sponsored by Brown University. Completed at 1 site in United States. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-03-23.

Sponsored by Brown University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
13 Years to 18 Years
Sex
All
01

Study summary

Phase 2: Open Trial N=12 adolescents will be enrolled into a single-arm pilot trial to test the adapted hatha yoga intervention

Read the detailed description

In Phase 2, the investigators will conduct an open single-arm pilot trial of our 12 week adapted hatha yoga intervention.

the investigators will enroll 12 adolescents in the open pilot trial.

02

Conditions studied

  • Depression

Browse trials for

03

In context

Depression

8,245 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 11 is below the median of 84 across 6,869 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Brown University is the lead sponsor of 288 studies on the registry; 38 are open to participants now.

Of its 26 completed or terminated interventional studies of FDA-regulated products, 19 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adolescents must have elevated depressive symptoms, defined by a score of 11 or higher on the Quick Inventory of Depression -Adolescent Version-- Clinician Rating (QIDS-A-CR), including endorsement of either sad mood or anhedonia on the QIDS.
  2. Other treatment for depression must be stable at baseline. Adolescents do not have to be in other treatment for depression, but, if they are, it must be stable for the past 12 weeks.
  3. Adolescents must be aged 13-18.
  4. Adolescents must be medically cleared for moderate physical activity by their primary care physician. This criterion may be met by a current (dated in the past year) statement from their pediatrician that the adolescent may participate in school or camp programs including physical education.
  5. Adolescents must be able to read and write English sufficient to complete informed consent and engage in interventions.
  6. Adolescents aged 13-17 must assent to be in the study, and their parent or legal guardian must consent to their participation. Adolescents aged 18 must consent to be in the study.
  7. Able to attend one of the class times.

Exclusion criteria

Exclusion Criteria:

  1. QIDS- A-CR may not be higher than a score of 21. This ensures that adolescents are not severely depressed.
  2. Adolescents who meet criteria for:

    • Current (past year) autism spectrum disorder (AS), if of sufficient severity to interfere with study treatment per clinician judgment;
    • Schizophrenia;
    • Bipolar disorder;
    • Clinically significant psychotic symptoms in the past month;
    • Anorexia or Bulimia in past 3 months
    • Substance use disorders in the past 12 months and symptoms are of sufficient severity to interfere with study treatment per clinician judgment These will be assessed with the Mini-International Neuropsychiatric Interview (MINI).
  3. Adolescents may not have current suicide ideation or behavior that warrants immediate treatment. They may have passive ideation (i.e., thoughts that life is not worth living), but may not have active suicide ideation, intent, plan, or an attempt within the previous 6 months.
  4. Adolescents cannot currently be engaged in or yoga classes, as this is the study intervention.
  5. Adolescents cannot be pregnant as yoga should be modified for pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Hatha Yoga

    12 weeks of modified Hatha Yoga specifically designed to be administered to teens with depression.

    Behavioral: Hatha Yoga

Interventions

  • BehavioralHatha Yoga

    12 weeks of Hatha Yoga

06

What researchers measure

Primary outcomes

  1. Acceptability

    Acceptability assessed based on number of participants who remained in the intervention (retention).

    Time frame: Post intervention (month 3)

  2. Credibility Expectancy Questionnaire (CEQ) - Credibility Subscale

    Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are scored on a range of 0-1. Higher scores indicate greater credibility.

    Time frame: Week 1

  3. Credibility Expectancy Questionnaire (CEQ) - Expectancy Subscale

    Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. Score ranges from 0-1 with higher scores indicating greater expectations.

    Time frame: Week 1

  4. The Client Satisfaction Questionnaire (CSQ-8)

    Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.

    Time frame: Post intervention (month 3)

  5. Home Practice Questionnaire

    Number of participants who met criteria for home practice (target of two practices per week) as assessed with a home practice questionnaire.

    Time frame: Post intervention (month 3)

  6. Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)

    Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.

    Time frame: Post intervention (month 3)

Secondary outcomes

  1. Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)

    Depression symptom severity at Month 3. The QIDS is a 17 item measure with scores ranging from 0-30. Higher scores indicate greater depressive symptoms.

    Time frame: post intervention (month 3)

07

Results

Posted Mar 23, 2022

Participant flow

Participant flow — Overall Study
MilestoneHatha Yoga
Started11
Completed9
Not completed2

Outcome measures

PrimaryAcceptability

Acceptability assessed based on number of participants who remained in the intervention (retention).

Time frame:
Post intervention (month 3)
Reported as:
Count of participants · Participants
Acceptability
ParticipantsHatha Yoga
Acceptability9
PrimaryCredibility Expectancy Questionnaire (CEQ) - Credibility Subscale

Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are scored on a range of 0-1. Higher scores indicate greater credibility.

Time frame:
Week 1
Reported as:
Mean · score on a scale
Credibility Expectancy Questionnaire (CEQ) - Credibility Subscale
score on a scaleHatha Yoga
Credibility Expectancy Questionnaire (CEQ) - Credibility Subscale0.76 ± 0.25
PrimaryCredibility Expectancy Questionnaire (CEQ) - Expectancy Subscale

Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. Score ranges from 0-1 with higher scores indicating greater expectations.

Time frame:
Week 1
Reported as:
Mean · score on a scale
Credibility Expectancy Questionnaire (CEQ) - Expectancy Subscale
score on a scaleHatha Yoga
Credibility Expectancy Questionnaire (CEQ) - Expectancy Subscale0.66 ± 0.29
PrimaryThe Client Satisfaction Questionnaire (CSQ-8)

Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.

Time frame:
Post intervention (month 3)
Reported as:
Mean · score on a scale
The Client Satisfaction Questionnaire (CSQ-8)
score on a scaleHatha Yoga
The Client Satisfaction Questionnaire (CSQ-8)26.2 ± 6.1
PrimaryHome Practice Questionnaire

Number of participants who met criteria for home practice (target of two practices per week) as assessed with a home practice questionnaire.

Time frame:
Post intervention (month 3)
Reported as:
Count of participants · Participants
Home Practice Questionnaire
ParticipantsHatha Yoga
Home Practice Questionnaire6
PrimarySystematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)

Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.

Time frame:
Post intervention (month 3)
Reported as:
Number · adverse events
Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)
adverse eventsHatha Yoga
Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)6
SecondaryQuick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)

Depression symptom severity at Month 3. The QIDS is a 17 item measure with scores ranging from 0-30. Higher scores indicate greater depressive symptoms.

Time frame:
post intervention (month 3)
Reported as:
Mean · score on a scale
Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)
score on a scaleHatha Yoga
Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)4.11 ± 2.66

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Hatha Yoga0/11 (0%)0/11 (0%)2/11 (18.2%)
Most frequent other events
Most frequent other events
EventHatha Yoga
InfectionBlood and lymphatic system disorders1/11
CeliacGastrointestinal disorders1/11
GI distressGastrointestinal disorders1/11
Gynecological issueGeneral disorders1/11

Baseline characteristics

Age, Continuous
Age, Continuous(years)Hatha Yoga
Mean15.8 ± 1.8
Sex: Female, Male
Sex: Female, Male(Participants)Hatha Yoga
Female10
Male1
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Hatha Yoga
White9
Multiracial and Other2
Region of Enrollment
Region of Enrollment(Participants)Hatha Yoga
United States11
08

Study locations

1 site
  • Butler Hospital
    Providence, Rhode Island 02906, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 10, 2020
  • Informed consent form · Apr 17, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — All IPD underlying publication if required by journal.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: One year after study collection.

Access criteria: Information available upon request, please send to PIs Lisa Uebelacker or Shirley Yen.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03831347
Lead sponsor
Brown University
Responsible party
Sponsor
First posted
Feb 5, 2019
Start date
Mar 1, 2019
Primary completion
Aug 14, 2019
Completion
Aug 29, 2019
Results posted
Mar 23, 2022
Last update
Mar 23, 2022

Study contacts

Lisa Uebelacker, PhD
principal investigator · Butler Hospital
Shirley Yen, PhD
principal investigator · Brown University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion